Product Information
METHYLPHENIDATE ER 18 MG TAB is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.5761 per EA under NDC 31722095201. Its NADAC has been published 364 times since Oct 16, 2019.
FDA first approved this application on Sep 3, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
18 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722095201
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211009FDA Approved
9/3/2019
TE Code
AB
On Market Since
9/3/2019
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE ER 18 MG TAB has been published 364 times since Oct 16, 2019, and over the history we have for it it has declined 88.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5761 per EA |
|---|---|
| All-time high | $5.1005 (Oct 16, 2019) |
| All-time low | $0.5230 (Jul 20, 2022) |
| 52-week high | $0.6989 |
| 52-week low | $0.5758 |
| Median price | $0.7246 |
| Average price | $1.1416 |
| Largest weekly change | -50.2% (Jul 22, 2020) |
| Weeks tracked | 364 |
| Tracking since | Oct 16, 2019 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Camber Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Methylphenidate Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE ER 18 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE ER 18 MG TAB, manufactured by Camber Pharmaceuticals Inc., is $0.5761 per EA (NDC 31722095201), effective Sep 30, 2026.
How has the price of METHYLPHENIDATE ER 18 MG TAB changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE ER 18 MG TAB has declined 88.7%. It has been tracked across 364 weekly CMS publications since Oct 16, 2019.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE ER 18 MG TAB?
Since Oct 16, 2019, the NADAC for METHYLPHENIDATE ER 18 MG TAB has ranged from a low of $0.5230 (Jul 20, 2022) to a high of $5.1005 (Oct 16, 2019), with a median of $0.7246 per EA.
Are there cheaper alternatives to METHYLPHENIDATE ER 18 MG TAB?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METHYLPHENIDATE ER 18 MG TAB, is $0.5758 per EA — about 0% below METHYLPHENIDATE ER 18 MG TAB.
Who manufactures METHYLPHENIDATE ER 18 MG TAB?
METHYLPHENIDATE ER 18 MG TAB (NDC 31722095201) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.